Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

NCT02033018 is registered in ClinicalTrials.gov with Instituto de Olhos de Goiania as lead sponsor.

NCT NCT02033018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02033018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
Lead sponsor
Instituto de Olhos de Goiania
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2013
Completion date
November 30, 2014
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal retinal neovascularization